<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Stop the Start: Therapeutics Targeting C5aR1 to Treat Early Rheumatoid Arthritis as a New Pathway to Precision Medicine

Nirmal K. Banda, PhD, MPhil, MS

by Department of Medicine | October 11, 2022

Watch the Department of Medicine's Oct. 11, 2022 Research & Innovation Conference – "Stop the Start: Therapeutics Targeting C5aR1 to Treat Early Rheumatoid Arthritis as a New Pathway to Precision Medicine" with Nirmal K. Banda, PhD, MPhil, MS, research professor in the Division of Rheumatology.

 

Topics: Research